124 related articles for article (PubMed ID: 34774990)
21. Development of a cell-based nonradioactive glucose uptake assay system for SGLT1 and SGLT2.
Kanwal A; Singh SP; Grover P; Banerjee SK
Anal Biochem; 2012 Oct; 429(1):70-5. PubMed ID: 22796500
[TBL] [Abstract][Full Text] [Related]
22. Expression of glucose transporters in human peritoneal mesothelial cells.
Schröppel B; Fischereder M; Wiese P; Segerer S; Huber S; Kretzler M; Heiss P; Sitter T; Schlöndorff D
Kidney Int; 1998 May; 53(5):1278-87. PubMed ID: 9573543
[TBL] [Abstract][Full Text] [Related]
23. Residual Gastric Dilatation Interferes with Metabolic Improvements Following Sleeve Gastrectomy by Upregulating the Expression of Sodium-Glucose Cotransporter-1.
Xia J; He Q; He M; Xu G; Tang Y; Ren Y
Obes Surg; 2019 Oct; 29(10):3324-3333. PubMed ID: 31201691
[TBL] [Abstract][Full Text] [Related]
24. Thyroid hormone regulation of the Na+/glucose cotransporter SGLT1 in Caco-2 cells.
Matosin-Matekalo M; Mesonero JE; Delezay O; Poiree JC; Ilundain AA; Brot-Laroche E
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):633-40. PubMed ID: 9729472
[TBL] [Abstract][Full Text] [Related]
25. Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.
Rieg T; Masuda T; Gerasimova M; Mayoux E; Platt K; Powell DR; Thomson SC; Koepsell H; Vallon V
Am J Physiol Renal Physiol; 2014 Jan; 306(2):F188-93. PubMed ID: 24226519
[TBL] [Abstract][Full Text] [Related]
26. BMAL1 controls glucose uptake through paired-homeodomain transcription factor 4 in differentiated Caco-2 cells.
Sussman W; Stevenson M; Mowdawalla C; Mota S; Ragolia L; Pan X
Am J Physiol Cell Physiol; 2019 Sep; 317(3):C492-C501. PubMed ID: 31216190
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs.
Kurata JS; Lin RJ
RNA; 2018 Jul; 24(7):966-981. PubMed ID: 29720387
[TBL] [Abstract][Full Text] [Related]
28. FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma.
Lei S; Yang J; Chen C; Sun J; Yang L; Tang H; Yang T; Chen A; Zhao H; Li Y; Du X
J Exp Clin Cancer Res; 2016 May; 35():79. PubMed ID: 27178057
[TBL] [Abstract][Full Text] [Related]
29. Cloning of a membrane-associated protein which modifies activity and properties of the Na(+)-D-glucose cotransporter.
Veyhl M; Spangenberg J; Püschel B; Poppe R; Dekel C; Fritzsch G; Haase W; Koepsell H
J Biol Chem; 1993 Nov; 268(33):25041-53. PubMed ID: 8227068
[TBL] [Abstract][Full Text] [Related]
30. Identifying novel therapeutic targets in gastric cancer using genome-wide CRISPR-Cas9 screening.
Zeng Z; Zhang X; Jiang CQ; Zhang YG; Wu X; Li J; Tang S; Li L; Gu LJ; Xie XY; Jiang YA
Oncogene; 2022 Apr; 41(14):2069-2078. PubMed ID: 35177812
[TBL] [Abstract][Full Text] [Related]
31. CRISPR-Cas9 Mediated NOX4 Knockout Inhibits Cell Proliferation and Invasion in HeLa Cells.
Jafari N; Kim H; Park R; Li L; Jang M; Morris AJ; Park J; Huang C
PLoS One; 2017; 12(1):e0170327. PubMed ID: 28099519
[TBL] [Abstract][Full Text] [Related]
32. Autocrine Sonic hedgehog signaling promotes gastric cancer proliferation through induction of phospholipase Cγ1 and the ERK1/2 pathway.
Ertao Z; Jianhui C; Chuangqi C; Changjiang Q; Sile C; Yulong H; Hui W; Shirong C
J Exp Clin Cancer Res; 2016 Apr; 35():63. PubMed ID: 27039174
[TBL] [Abstract][Full Text] [Related]
33. Cloning and expression of bovine sodium/glucose cotransporters.
Zhao FQ; Zheng YC; Wall EH; McFadden TB
J Dairy Sci; 2005 Jan; 88(1):182-94. PubMed ID: 15591382
[TBL] [Abstract][Full Text] [Related]
34. Exome Array Analysis Identifies Variants in SPOCD1 and BTN3A2 That Affect Risk for Gastric Cancer.
Zhu M; Yan C; Ren C; Huang X; Zhu X; Gu H; Wang M; Wang S; Gao Y; Ji Y; Miao X; Yang M; Chen J; Du J; Huang T; Jiang Y; Dai J; Ma H; Zhou J; Wang Z; Hu Z; Ji G; Zhang Z; Shen H; Shi Y; Jin G
Gastroenterology; 2017 Jun; 152(8):2011-2021. PubMed ID: 28246015
[TBL] [Abstract][Full Text] [Related]
35. LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose.
Powell DR; Smith M; Greer J; Harris A; Zhao S; DaCosta C; Mseeh F; Shadoan MK; Sands A; Zambrowicz B; Ding ZM
J Pharmacol Exp Ther; 2013 May; 345(2):250-9. PubMed ID: 23487174
[TBL] [Abstract][Full Text] [Related]
36. miR-302b regulates cell cycles by targeting CDK2 via ERK signaling pathway in gastric cancer.
Liu FY; Wang LP; Wang Q; Han P; Zhuang WP; Li MJ; Yuan H
Cancer Med; 2016 Sep; 5(9):2302-13. PubMed ID: 27465546
[TBL] [Abstract][Full Text] [Related]
37. Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure.
Sayour AA; Oláh A; Ruppert M; Barta BA; Horváth EM; Benke K; Pólos M; Hartyánszky I; Merkely B; Radovits T
Cardiovasc Diabetol; 2020 Sep; 19(1):159. PubMed ID: 32998746
[TBL] [Abstract][Full Text] [Related]
38. Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS.
Zhuo W; Liu Y; Li S; Guo D; Sun Q; Jin J; Rao X; Li M; Sun M; Jiang M; Xu Y; Teng L; Jin Y; Si J; Liu W; Kang Y; Zhou T
Gastroenterology; 2019 Feb; 156(3):676-691.e11. PubMed ID: 30445010
[TBL] [Abstract][Full Text] [Related]
39. MRFAP1 plays a protective role in neddylation inhibitor MLN4924-mediated gastric cancer cell death.
Hu L; Bai ZG; Ma XM; Bai N; Zhang ZT
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8273-8280. PubMed ID: 30556867
[TBL] [Abstract][Full Text] [Related]
40. Knockout of CTNNB1 by CRISPR-Cas9 technology inhibits cell proliferation through the Wnt/β-catenin signaling pathway.
Guan L; Zhu S; Han Y; Yang C; Liu Y; Qiao L; Li X; Li H; Lin J
Biotechnol Lett; 2018 Mar; 40(3):501-508. PubMed ID: 29249062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
